Success Stories

Since 2005, EyeQ Research has completed projects for over 80 clients in eye care and other healthcare markets, including innovators, market leaders, and investors.

A majority of these client relationships have grown into multi-project engagements, supporting a wide range of strategic transactions.

Mergers and Acquisitions
 

EyeQ Research has built revenue and valuation models to help clients achieve successful M&A outcomes, including:

  • Tear Film Innovations and WaveTec Vision in their acquisitions by Alcon

  • IanTech in its acquisition by Carl Zeiss Meditec

  • TearScience in its acquisition by Johnson & Johnson Vision

Consulting services for these clients included:

  • Development of highly referenced market and revenue models

  • Quantification of potential strategic revenue synergies for acquirers

  • Valuation analysis under multiple scenarios

Fundraising and Investment

 

EyeQ Research has completed a wide range of consulting projects in support of fundraising activities and investment decisions:

  • Built a comprehensive global keratoconus market and revenue model for Avedro, in support of the company's initial public offering.

 

  • Assisted an institutional investor in its evaluation of Alimera Sciences, including in-depth interviews with retina specialists and development of a comprehensive population-based model of the US diabetic macular edema market.

  • Supported early stage fundraising activities for Oculeve, including validation of clinical need and product concept through interviews with key opinion leaders in dry eye. Oculeve was later acquired by Allergan.

  • Conducted independent due diligence for a leading healthcare venture capital firm, leading to an investment in Transcend Medical. The project included a detailed analysis of clinical data and a review of reimbursement status. EyeQ Research had previously built a glaucoma market model for Transcend, and contributed to the company's business plan. Transcend was later acquired by Alcon.

New Business Ventures
 

EyeQ Research has supported eye care innovators in the formation of important new companies:

  • Provided strategic advisory to SightLife in the establishment of CorneaGen, including prioritization of strategic objectives, review of potential organizational structures and growth strategies, modeling of the global market size and competitive landscape, and identification of key opportunities, challenges, and risks.

  • Collaborated with ophthalmic incubator ForSight Labs in the establishment of four of its VISION companies in the fields of drug delivery, glaucoma, and refractive surgery. Projects included qualitative research, market sizing and segmentation, and analyses of clinical and cost effectiveness data.

  • Conducted due diligence for RoundTable Healthcare Partners in the acquisition of the BD Ophthalmic Systems and formation of Beaver-Visitec International (BVI), including review of key market trends, interviews with ophthalmic surgeons and industry sources, and identification of additional potential M&A targets. RoundTable later sold BVI to TPG Capital.

 

© 2005-2020 EyeQ Research/Lachman Consulting LLC. All rights reserved.

  • LinkedIn Clean